Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
9,808 studies for “Japan”
Sponsor: Merck Sharp & Dohme LLC
Lymphoma, Large B-Cell, Diffuse
United States, Belgium, Germany, Ireland, Israel +4 more
Sponsor: Amgen
Non-Small Cell Lung Cancer (NSCLC)
United States, Argentina, Australia, Austria, Belgium +33 more
- Tezepelumab PRO StudyCompleted
Sponsor: AstraZeneca
Asthma
Japan
Sponsor: Merck Sharp & Dohme LLC
Prostate Cancer · Prostatic Neoplasms
United States, Argentina, Australia, Austria, Brazil +30 more
- A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD)Active Not Recruiting
Sponsor: Ionis Pharmaceuticals, Inc.
Alexander Disease
United States, Australia, Canada, Israel, Italy +3 more
Sponsor: Eli Lilly and Company
Diabetes Mellitus, Type 1
United States, Australia, Belgium, Brazil, Canada +15 more
Sponsor: BeOne Medicines
B-cell Malignancy · Marginal Zone Lymphoma · Follicular Lymphoma · Non-Hodgkin Lymphoma
United States, Australia, Brazil, Canada, China +11 more
Sponsor: Eli Lilly and Company
Smoking
United States, China, Japan
- A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular EdemaRecruiting
Sponsor: Boehringer Ingelheim
Macular Edema
United States, China, Czechia, Germany, Hungary +4 more
Sponsor: argenx
Chronic Inflammatory Demyelinating Polyneuropathy · CIDP · Chronic Inflammatory Demyelinating Polyradiculoneuropathy
United States, Argentina, Austria, Brazil, Bulgaria +19 more
Sponsor: Merck Sharp & Dohme LLC
Metastatic Esophageal Squamous Cell Carcinoma
United States, Argentina, Canada, Chile, China +20 more
- A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed SteroidsActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Primary Immune Thrombocytopenia
United States, Argentina, Austria, Belgium, China +19 more
Sponsor: Eli Lilly and Company
Ovarian Neoplasms · Fallopian Tube Neoplasms · Peritoneal Neoplasms · Neoplasm Metastasis
United States, Australia, Austria, Belgium, Brazil +22 more
Sponsor: Boehringer Ingelheim
Kidney Disease, Chronic
United States, Argentina, Australia, Belgium, Brazil +15 more
Sponsor: Eli Lilly and Company
Elevated Lp(a) · Atherosclerotic Cardiovascular Disease (ASCVD)
United States, Argentina, Australia, Austria, Belgium +23 more
Sponsor: Celgene
Relapsed or Refractory Multiple Myeloma
United States, Argentina, Australia, Austria, Belgium +24 more
- A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Neoplasm Malignant
United States, Australia, Canada, Chile, China +14 more
- A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaActive Not Recruiting
Sponsor: AbbVie
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +39 more
Sponsor: UCB Biopharma SRL
Hidradenitis Suppurativa
United States, Australia, Belgium, Bulgaria, Canada +14 more
Sponsor: Eli Lilly and Company
Asthma
United States, Argentina, Brazil, Canada, China +7 more
Sponsor: Daiichi Sankyo
Advanced Solid Tumor · Melanoma · Head and Neck Cancer · Gastric Cancer
United States, Australia, Belgium, Canada, China +11 more
Sponsor: Novartis Pharmaceuticals
Tuberous Sclerosis Complex
United States, Australia, Belgium, Canada, Colombia +13 more
Sponsor: Eli Lilly and Company
Peripheral Arterial Disease
United States, Argentina, Australia, Brazil, Canada +11 more
Sponsor: AbbVie
Episodic Migraine
United States, Belgium, Canada, Denmark, France +11 more
Sponsor: Eli Lilly and Company
Metabolic Dysfunction-Associated Steatotic Liver Disease
United States, Argentina, Australia, Austria, Belgium +29 more
9,808 studies found